Media "Classics"

Media "Classics" (6)

The best write-ups on Cytori from the past.

Tuesday, 17 April 2012 06:50

CYTX: a Low Risk Stem Cell Play

Written by
The biotech company has had successful clinical trials yet is unloved by the market. Here's why investors should start a position now. Written by James Anderson Typically, early-stage biotech companies are considered to have a binary outcome. If successful with the first product that enters clinical trials the company moves on to raise more money through stock sales, enter a partnership with a large pharmaceutical company, or sell the company. In each case, investors do well. However, if the first product fails in its clinical trial, there is a good chance the company will run out of money and fail. Hence, it’s binary -- all or nothing. Stem cell therapies have been garnering significant attention as the field of regenerative medicine starts to evolve. As one would expect, there are a number of start-up biotech companies in the field.
Saturday, 14 April 2012 16:45

Sign-on SD: Stem Cells from Fat

Written by
San Diego's Cytori banks on a new process to help damaged hearts Getting rid of that spare tire around your middle could help your heart in more ways than you might expect, according to a San Diego biotechnology company. Cytori Therapeutics has developed a machine that pulls stem cells and other regenerative cells out of fat so they can be re-injected into the body to repair tissue damaged by heart attack or disease. Several studies, including some in which Cytori scientists have participated, have shown that stem cells and other regenerative material from fat can help build blood supply and restore blood flow to cardiac muscle that has been damaged by a heart attack.
Friday, 13 April 2012 11:33

The Analyst´s view

Written by
On January 24, 2010 Joe Feshbach (picture- here with his wife Cindy) published an article on his Instablog at Seeking Alpha, written by his friend, former investment banker and author of the book "Lost Star of Myth and Time"- Walter Cruttenden. An absolute classic for believers in Cytori technology. Joe was one of those believers and after attending the first Cellsociety annual meeting in San Diego in February 2011 decided with his brother Matt and other investors, to put his money where his "believes" were and started to organize the construction of a cardiac clinic on the Bahama´s using Cytori tech- i.e.Celution One. Unfortunately Joe suffered a massive heart attack on August 8 2011 whilst on a biketrip and never could see his plans come to fruition.   
Page 1 of 2

Copyright Information

Copyright Fas Kuiters © 2019-2020 raccoon-lodge.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.